Argenx is a Dutch biopharmaceutical company focused on developing antibody-based therapies for rare autoimmune diseases... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LTL | 72.52 | 2.45 | +3.50% |
| ProShares Ultra Communication Services | |||
| BMAR | 44.15 | 0.55 | +1.27% |
| Innovator U.S. Equity Buffer ETF™ - Mar | |||
| OSCV | 33.86 | 0.34 | +1.01% |
| Opus Small Cap Value Plus ETF | |||
| NZF | 11.59 | 0.11 | +0.96% |
| Nuveen Municipal Credit Income Fund | |||
| PSCE | 34.63 | -0.01 | -0.03% |
| Invesco S&P SmallCap Energy ETF | |||
A.I.dvisor indicates that over the last year, ARGNF has been loosely correlated with ARGX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ARGNF jumps, then ARGX could also see price increases.
| Ticker / NAME | Correlation To ARGNF | 1D Price Change % | ||
|---|---|---|---|---|
| ARGNF | 100% | N/A | ||
| ARGX - ARGNF | 54% Loosely correlated | -0.87% | ||
| BLUE - ARGNF | 45% Loosely correlated | -5.99% | ||
| MNKD - ARGNF | 30% Poorly correlated | +0.66% | ||
| TNXP - ARGNF | 25% Poorly correlated | +13.30% | ||
| ROIV - ARGNF | 24% Poorly correlated | +2.98% | ||
More | ||||